Construction of pH-Sensitive Dynamic Composite Hydrogels and Their Local Targeted Antitumor Research
Authors:
- 27 October 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (22) , 10920-10931
Abstract
The treatment of solid tumors is often limited by traditional methods such as surgery and chemotherapy. These methods potentially kill cancer cells but cause significant systemic toxicity and tissue damage. This research introduces a pH-responsive injectable hydrogel (named as Gel-FOEDS) containing fluorinated ortho-ester-loaded dasatinib (DAS) and sunitinib (SUN) and provides a potential strategy to overcome certain limitations of traditional therapies. This gel acts as a “drug pool” that delivers, penetrates, and retains drugs—enabling sustained, deep tumor delivery. Studies have shown that FOE can carry DAS and SUN to escape from the hydrogel rapidly and penetrate deep into the tissue. The imine bond's acid instability in the hydrogel and FOE's specific response to the acidic microenvironment work together for targeted, controllable release of DAS and SUN at the tumor site. The self-assembly of DAS and SUN forms nanoparticles (NPs), which prolongs their retention in tumor tissues. In the mouse solid tumor model, the Gel-FOEDS group demonstrated the strongest antitumor activity, with some tumor-bearing mice achieving complete tumor regression. Our results indicate this composite hydrogel provides an efficient local delivery solution for tyrosine kinase inhibitors (TKIs) and offers a low-side-effect strategy for the treatment of solid tumors.Keywords
Funding Information
- Anhui Provincial Department of Education (KJ2018ZD003)
- National Natural Science Foundation of China (21174054)
- Natural Science Foundation of Anhui Province (2008085ME136)
- Anhui Provincial Key Research and Development Plan (202004e11020001)
- Anhui Province (GXXT-2019-009)
This publication has 43 references indexed in Scilit:
- Tailored Nanogel Network Topology Enables Clinical Ultrasound‐Induced Mechanochemical Activation for In Vivo TherapyAngewandte Chemie International Edition, 2026
- Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapyActa Pharmaceutica Sinica B, 2024
- Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approachesActa Pharmaceutica Sinica B, 2024
- Recent progress in pyroptosis probes and inducersAdvanced Sensor and Energy Materials, 2024
- Advanced nanoscale drug delivery systems for bone cancer therapyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- Coordinated regulation of BACH1 and mitochondrial metabolism through tumor-targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapyActa Pharmaceutica Sinica B, 2022
- Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatmentActa Pharmaceutica Sinica B, 2021
- Dynamic micelles with detachable PEGylation at tumoral extracellular pH for enhanced chemotherapyAsian Journal of Pharmaceutical Sciences, 2020
- What turns CREB on? And off? And why does it matter?Cellular and Molecular Life Sciences, 2020
- Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle trackingBiomaterials, 2019